JP2002507616A5 - - Google Patents

Download PDF

Info

Publication number
JP2002507616A5
JP2002507616A5 JP2000537879A JP2000537879A JP2002507616A5 JP 2002507616 A5 JP2002507616 A5 JP 2002507616A5 JP 2000537879 A JP2000537879 A JP 2000537879A JP 2000537879 A JP2000537879 A JP 2000537879A JP 2002507616 A5 JP2002507616 A5 JP 2002507616A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
hydrogen
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000537879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002507616A (ja
Filing date
Publication date
Priority claimed from AT0051598A external-priority patent/AT406772B/de
Application filed filed Critical
Publication of JP2002507616A publication Critical patent/JP2002507616A/ja
Publication of JP2002507616A5 publication Critical patent/JP2002507616A5/ja
Withdrawn legal-status Critical Current

Links

JP2000537879A 1998-03-23 1999-03-19 抗生物質としての環状アミノグアニジン置換基を有するセファロスポリン Withdrawn JP2002507616A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0051598A AT406772B (de) 1998-03-23 1998-03-23 Antibakterielle 7-acylamino-3-iminomethyl- cephalosporine und verfahren zu deren herstellung
AT515/98 1998-03-23
PCT/EP1999/001853 WO1999048896A1 (en) 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents as antibiotics

Publications (2)

Publication Number Publication Date
JP2002507616A JP2002507616A (ja) 2002-03-12
JP2002507616A5 true JP2002507616A5 (enExample) 2006-05-11

Family

ID=3492649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000537879A Withdrawn JP2002507616A (ja) 1998-03-23 1999-03-19 抗生物質としての環状アミノグアニジン置換基を有するセファロスポリン

Country Status (25)

Country Link
US (1) US6440957B1 (enExample)
EP (2) EP1930335A1 (enExample)
JP (1) JP2002507616A (enExample)
KR (1) KR100696422B1 (enExample)
CN (1) CN1188418C (enExample)
AR (1) AR015248A1 (enExample)
AT (1) AT406772B (enExample)
AU (1) AU749735B2 (enExample)
BR (1) BR9908960A (enExample)
CA (1) CA2324953C (enExample)
CO (1) CO5080739A1 (enExample)
HU (1) HUP0101603A3 (enExample)
ID (1) ID26567A (enExample)
IL (2) IL138477A0 (enExample)
MY (1) MY119841A (enExample)
NO (1) NO20004760L (enExample)
NZ (1) NZ506908A (enExample)
PE (1) PE20000360A1 (enExample)
PL (1) PL343094A1 (enExample)
RU (1) RU2245884C2 (enExample)
SK (1) SK14152000A3 (enExample)
TR (1) TR200002749T2 (enExample)
TW (1) TWI250983B (enExample)
WO (1) WO1999048896A1 (enExample)
ZA (1) ZA200004850B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693095B2 (en) * 1997-04-01 2004-02-17 Biochemie Gesellschaft M.B.H. Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
DE102007052891A1 (de) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Verfahren zur Stabilisierung von olefinisch ungesättigten Monomeren
DE102013204950A1 (de) 2013-03-20 2014-09-25 Evonik Industries Ag Verfahren und Zusammensetzung zur Inhibierung der Polymerisation von Cyclopentadienverbindungen
ES2624415T3 (es) 2014-09-08 2017-07-14 Evonik Degussa Gmbh (Tio)acetales fenólicos como agentes inhibidores de la polimerización de monómeros olefínicamente insaturados
TWI669317B (zh) 2014-09-22 2019-08-21 德商贏創德固賽有限責任公司 反應性單體的改良製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943408C (de) * 1953-03-31 1956-05-17 Bayer Ag Verfahren zur Darstellung von Bisguanylhydrazonen
FI851934A7 (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporiinijohdannaisia.
GB8721568D0 (en) * 1987-09-14 1987-10-21 Fujisawa Pharmaceutical Co Cephem compounds
NZ308518A (en) * 1995-05-11 2000-01-28 Biochemie Gmbh Antibacterial cephalosporins
NZ337732A (en) * 1997-04-01 2001-09-28 Biochemie Gmbh Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates

Similar Documents

Publication Publication Date Title
JP2007516286A5 (enExample)
JP2007501809A5 (enExample)
JP2002539128A5 (enExample)
CA2224067A1 (en) Diphosphonate derivatives of therapeutic agents
JP2013540114A5 (enExample)
JP2010513434A5 (enExample)
JP2012508249A5 (enExample)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
JP2005527576A5 (enExample)
TW474935B (en) Cephalosporin antibiotics
CN1148596A (zh) 新晶形无水7-([1α,5α,6α]-6-氨基-3-氮杂二环[3.1.0]己-3-基)-6-氟-1-(2,4-二氟苯基)-1,4-二氢-4-氧代-1,8-二氮杂萘-3-羧酸甲磺酸盐
JP2013515037A5 (enExample)
FR2512448A1 (fr) Isoquinoleinium-betaines de cephalosporine et son application pharmaceutique
MXPA03010002A (es) Compuestos de cefemo.
JP2002507616A5 (enExample)
US20020115650A1 (en) Cephalosporin antibiotics and prodrugs thereof
EP0357089B1 (en) Novel cephem compound as an antimicrobial agent and its preparation
US5747484A (en) Crystalline cepham acid addition salts and processes for their preparation
EP1101769A3 (en) Nitrogen containing erythromycin derivatives
JPH0899978A (ja) セファロスポリン誘導体
JP2005526073A5 (enExample)
RU2000126469A (ru) Цефалоспорины, содержащие циклические аминогуанидиновые заместители, как антибиотики
JP4656798B2 (ja) セフェム化合物
JPWO2021041616A5 (enExample)
HUP9903621A2 (hu) Cefalosporinszármazékok